Time to rethink how we diagnose Alzheimer's disease

With all the focus on Alzheimer's disease in recent years as a result of the aging population, what have we learned? A symposium at The North American Menopause Society (NAMS) Annual Meeting in San Diego, Oct. 3-6, will not only review conflicting evidence regarding the best way to diagnose the disease, but also the latest thinking on the neurodegeneration that often begins during the menopause transition.